(Abstracted from J Assist Reprod Genet 2017;34:975–981)
Advancements in the efficacy of comprehensive chromosomal screening (CCS), namely, the ability to detect aneuploidy in all 24 human chromosomes, have established it as a cornerstone of infertility care. Recently, the development of high-throughput, massively parallel sequencing for use with CCS has led to highly accurate, simultaneous screening of multiple samples.
Reproductive Medicine Associates of New Jersey (D.G., T.X., R.T.S., N.R.T.); and Foundation for Embryonic Competence (X.T., A.L., Y.Z., J.L., R.Z.), Basking Ridge, NJ